Silver Book Fact

An experimental drug may help those women whose breast cancer worsens despite use of other therapies. The medicine was shown in studies to nearly double the time breast cancer was suppressed. It is also thought that it may cross the blood-brain barrier, suppressing the spread of breast cancer to the brain.

Pollack, Andrew. New Drug Holds Promise for Type of Breast Cancer. The New York Times. http://www.nytimes.com/2006/06/04/health/04cancer.html?ex=1159329600&en=691f887bb3d95f4b&ei=5070

Reference

Title
New Drug Holds Promise for Type of Breast Cancer
Publication
The New York Times
Authors
Pollack, Andrew
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • The standard treatment for prostate cancer used to require radical prostatectomy. Now, less invasive therapies like brachytherapy have been shown to have equal outcomes with fewer side effects.  
  • Surgical biopsy for lumps in the breast was found by one study to cost 2 1/2 to 3 times more than image-guided core-needle biopsy ($698 versus $243).  
  • Baseline lung cancer screening would lead to more than 130,000 additional survivors in 2012.  
  • Use of a monocolonal antibody with adjuvant chemotherapy in HER2+ individuals with operable cancer was associated with a 33 percent reduction in risk of death.